Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes-Reference-Cited by-同舟云学术

Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes

Published:2020-07 Issue: Volume:111 Page:386-397
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Chen I-Ju,Cheng Yi-An,Ho Kai-Wen,Lin Wen-Wei,Cheng Kai-Wen,Lu Yun-Chi,Hsieh Yuan-Chin,Huang Chien-Chiao,Chuang Chih-Hung,Chen Fang-Ming,Su Yu-Cheng,Roffler Steve R.,Cheng Tian-Lu^ORCID

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference56 articles.

1. Antibody therapy of cancer;Scott;Nat Rev Cancer,2012

2. Advances and Challenges of Liposome Assisted Drug Delivery;Sercombe;Front Pharmacol,2015

3. Trastuzumab–mechanism of action and use in clinical practice;Hudis;N Engl J Med,2007

4. New insights into anti-HER-2 receptor monoclonal antibody research;Kumar;Semin Oncol,2000

5. Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer;Musolino;J Clin Oncol,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advanced lipid-based nanomedicines for overcoming cancer resistance;Cancer Drug Resistance;2024-06-21

2. Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies;Biotechnology Advances;2024-05

3. Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A review;Journal of Controlled Release;2023-07

4. Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation;Journal of Drug Delivery Science and Technology;2023-02

5. Structural determination of an antibody that specifically recognizes polyethylene glycol with a terminal methoxy group;Communications Chemistry;2022-08-01